BTS Group signs agreement with a major Pharma company worth up to $4.485m over three years
(Thomson Reuters ONE) -
Stockholm, Sweden and Stamford, USA - BTS Group AB (publ), - the global leader
in accelerating strategic alignment and execution, has signed an agreement worth
up to US$4.485m. The agreement spans three years and BTS has been engaged to
develop and deliver an innovative business leadership development program at an
existing global pharmaceuticals client.
The leadership development program's purpose is to build business leadership and
execution capability in up to 5,000 middle level leaders worldwide.
"We are honored that this existing partner has chosen BTS to build and manage
this important strategic initiative which is focused on building business
leadership and execution capability across the globe." says Henrik Ekelund,
President and CEO of BTS Group AB. "This is strong evidence of our ability to
provide a systematic process to help global organizations accelerate business
results by innovating how their leaders learn, change and improve."
The contract follows an initial deal to provide a broad curriculum of business
leadership development programs for frontline leaders around the globe. This
curriculum is up and running and has the objective of building business
leadership and execution capability in over 9,000 frontline managers worldwide.
The initiative has strong involvement and is supported by the executive
leadership team, who see this initiative as critical to transforming the
organization and driving execution of their strategic priorities.
Both initiatives provide a wide range of learning components, including initial
assessments, online communities, online coursework, and immersive scenario and
business simulations. These experiential learning tools will be combined to
deliver a comprehensive continuum of learning.
They also incorporates the BTS' Advantage Way(TM) process, which engages senior
leaders in a way that creates strong "line of sight" from each learner to their
organization's goals and strategic priorities. The process includes built-in
mechanisms that capture outcomes, ROI, and anecdotal success cases for
replication across the firm.
BTS will develop and deliver the custom middle level manager initiative in 12
different languages at client locations across the globe.
For more information, please contact;
Thomas Ahlerup
Senior Vice President
Corporate Communications and Investor Relations
BTS Group AB
Phone +46-8-5870 7002
Mobile +46-768-966 300
E-mail thomas.ahlerup(at)bts.com
About BTS Group AB
BTS partners with leading companies to accelerate strategy alignment and
execution, innovating how organizations learn, grow and improve. BTS is the
world leader in customized business simulations and discovery-based learning
solutions that enable leading corporations to grow and become successful through
change and improvement processes.
BTS adds value to its clients through three practice areas: Strategic Alignment
& Business Acumen, Leader-ship & Management, and Sales Force Transformation.
BTS also has strong capabilities in Operational Excellence & Project Management
and offer an innovative Engage for Change process.
BTS has approximately 300 highly talented employees serving more than 400
clients including 40 of the US Fortune 100 companies and 27 of the Global
Fortune 100 largest corporations in the world. In 2010 BTS revenues was SEK 694
million.
Recent selected BTS clients include AT&T, Ericsson, Rio Tinto, BBVA, Standard
Chartered Bank, Kimberly-Clark, Sony, Unilever.
BTS serves its clients from Stockholm, Helsinki, Amsterdam, Brussels, London,
Madrid, Bilbao, New York, Stamford, Philadelphia, Scottsdale, Los Angeles, San
Francisco, Chicago, Mexico City, Sao Paolo, Johannesburg, Sydney, Melbourne,
Singapore, Mumbai, Bangkok, Seoul, Shanghai, Taipei and Tokyo.
BTS is a public company listed on the NASDAQ-OMX Stockholm and trades under the
symbol BTS B.
For more information please visit www.bts.com.
Disclaimer
Every care has been taken in the translation of this press release. In the event
of discrepancies, however, the Swedish original will supersede the English
translation
Press release PDF:
http://hugin.info/132982/R/1537386/469220.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BTS Group AB via Thomson Reuters ONE
[HUG#1537386]
Unternehmensinformation / Kurzprofil:
Datum: 10.08.2011 - 09:41 Uhr
Sprache: Deutsch
News-ID 57106
Anzahl Zeichen: 5284
contact information:
Town:
STOCKHOLM
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 239 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BTS Group signs agreement with a major Pharma company worth up to $4.485m over three years"
steht unter der journalistisch-redaktionellen Verantwortung von
BTS Group AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
